Anchyra Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.7M Buy
6,697
+339
+5% +$79K 0.41% 47
2026
Q1
$1.55M Buy
6,358
+351
+6% +$81.8K 0.47% 42
2025
Q4
$1.24M Buy
+6,007
New +$1.19M 0.38% 55

Other funds holding JNJ

Anchyra Partners's JNJ Position: Q2 2026 in Review

Anchyra Partners increased its Johnson & Johnson (JNJ) stake by 5.3% in Q2 2026, buying an estimated $79K and bringing the position to 6,697 shares worth $1.7M. The position accounts for 0.41% of the portfolio, ranked #47.

Anchyra Partners first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. 3,174 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Anchyra Partners held 6,697 shares of Johnson & Johnson worth $1.7M as of Q2 2026.
  • Anchyra Partners bought 339 Johnson & Johnson shares in Q2 2026, an estimated $79K.
  • Johnson & Johnson made up 0.41% of Anchyra Partners's portfolio in Q2 2026, its #47 holding.
  • Anchyra Partners first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
  • 3,174 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Anchyra Partners's 13F filing for Q2 2026, filed 23 Jul 2026.